Viewing Study NCT06699459

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:01 PM
Ignite Modification Date: 2025-12-30 @ 2:01 AM
Study NCT ID: NCT06699459
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-11-21
First Post: 2024-11-13
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC
Sponsor: Sir Run Run Shaw Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Biliary Tract Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Biliary Tract Carcinoma View
None Adjuvant treatment View
None Resectable View
None Irinotecan liposomes View
None Capecitabine View